Current approaches to the discovery of novel inhaled medicines
Open Access
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 23 (10) , 1705-1717
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Human Lung Small Airway-on-a-Chip Protocol2017
- Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled DrugsCPT: Pharmacometrics & Systems Pharmacology, 2016
- Development of a Novel Lung Slice Methodology for Profiling of Inhaled CompoundsJournal of Pharmaceutical Sciences, 2016
- Modifying the Release Properties of Liposomes Toward Personalized MedicineJournal of Pharmaceutical Sciences, 2014
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5–11 years with persistent asthma: A randomized trialClinical Pharmacology in Drug Development, 2013
- Pulmonary Absorption Rate and Bioavailability of Drugs in Vivo in Rats: Structure–Absorption Relationships and Physicochemical Profiling of Inhaled DrugsJournal of Pharmaceutical Sciences, 2003
- Comparison of the Bronchodilating Effects of Inhaled Formoterol, Salmeterol and Salbutamol in Asthmatic PatientsPulmonary Pharmacology & Therapeutics, 2002
- Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after InhalationThe Journal of Clinical Pharmacology, 1997
- Isolated, Electrically-stimulated Airway Preparations—Their Use in Determiningβ-Adrenoceptor Agonist ActivityPulmonary Pharmacology, 1996
- β-Agonistic properties of tulobuterol, a newβ-sympathicomimetic Drug, and its effects on pulmonaryβ-adrenoceptor characteristicsLung, 1990